OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Jinhua Qinggan granules attenuates acute lung injury by promotion of neutrophil apoptosis and inhibition of TLR4/MyD88/NF-κB pathway
Yanhui Zhu, Qianqian Han, Lei Wang, et al.
Journal of Ethnopharmacology (2022) Vol. 301, pp. 115763-115763
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Potential herb–drug interactions between anti-COVID-19 drugs and traditional Chinese medicine
Ling Ye, Shicheng Fan, Pengfei Zhao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 9, pp. 3598-3637
Open Access | Times Cited: 25

Advances in nanomaterial-targeted treatment of acute lung injury after burns
Shuo Zhang, Xinyu Zhao, Yuhao Xue, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7

A molecular toxicological study to explore potential health risks associated with ultrafine particle exposure in cold and humid indoor environments
Ziyu Shu, Shuo Qing, Yang Xu, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 289, pp. 117638-117638
Open Access

Luteolin Mitigates Acute Lung Injury Through Immune Modulation and Antinecroptosis Effects by Targeting the BTK and FLT3 Signaling Pathways
Zhixing Cao, Huanan Rao, Wenya Yang, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access

Interplay of TLR4 and SARS-CoV-2: Unveiling the Complex Mechanisms of Inflammation and Severity in COVID-19 Infections
Njinju Asaba Clinton, Cyril Jabea Ekabe, Humblenoble Stembridge Ayuk, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 5077-5091
Open Access | Times Cited: 5

Shiwei Qingwen decoction regulates TLR4/NF-κB signaling pathway and NLRP3 inflammasome to reduce inflammatory response in lipopolysaccharide-induced acute lung injury
Qian Zhang, Cheng‐Xiong Yang, Shangzhi Ma, et al.
Journal of Ethnopharmacology (2023) Vol. 313, pp. 116615-116615
Closed Access | Times Cited: 11

Recent advances towards natural plants as potential inhibitors of SARS-Cov-2 targets
Zhouman He, Jia Yuan, Yuan‐wen Zhang, et al.
Pharmaceutical Biology (2023) Vol. 61, Iss. 1, pp. 1186-1210
Open Access | Times Cited: 9

Bakuchiol regulates TLR4/MyD88/NF-κB and Keap1/Nrf2/HO-1 pathways to protect against LPS-induced acute lung injury in vitro and in vivo
Li Zhao, Zhengliang Zhang, Ping Li, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 3301-3312
Closed Access | Times Cited: 5

The Role of the Nuclear Factor-Kappa B (NF-κB) Pathway in SARS-CoV-2 Infection
Periyanaina Kesika, Subramanian Thangaleela, S. Natarajan, et al.
Pathogens (2024) Vol. 13, Iss. 2, pp. 164-164
Open Access | Times Cited: 1

Shuangdan Jiedu Decoction improved LPS-induced acute lung injury by regulating both cGAS-STING pathway and inflammasome
Qing Yao, Jincai Wen, Simin Chen, et al.
Journal of Ethnopharmacology (2024) Vol. 336, pp. 118661-118661
Closed Access | Times Cited: 1

Sodium houttuyfonate induces bacterial lipopolysaccharide shedding to promote macrophage M1 polarization against acute bacterial lung infection
Mengxue Hu, Feng Jin, Cangcang Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117358-117358
Open Access | Times Cited: 1

“Three medicines and three formulas” in COVID-19: from bench to bedside
Guangxu Xiao, Simeng Wang, Ruijiao Wang, et al.
Acupuncture and Herbal Medicine (2023) Vol. 3, Iss. 4, pp. 309-322
Open Access | Times Cited: 4

Practice and principle of traditional Chinese medicine for the prevention and treatment of COVID-19
Linhua Zhao, Chuanxi Tian, Yingying Yang, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 6, pp. 1014-1029
Closed Access | Times Cited: 4

Liensinine reduces acute lung injury brought on by lipopolysaccharide by inhibiting the activation of the NF-κB signaling pathway through modification of the Src/TRAF6/TAK1 axis
Huizhen Chen, Feixue Liu, Da‐Peng Dai, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 2, pp. 1475-1488
Closed Access | Times Cited: 3

Monochasma savatieri Franch. protects against acute lung injury via α7nAChR-TLR4/NF-κB p65 signaling pathway based on integrated pharmacology analysis
Mantong Zhao, Mengru Yang, Jieyong Du, et al.
Journal of Ethnopharmacology (2023) Vol. 321, pp. 117487-117487
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top